Immune evasion by dormant disseminated cancer cells: A Fermi paradox?

Anna Adam-Artigues, Luis E. Valencia Salazar, Julio A. Aguirre-Ghiso

Research output: Contribution to journalComment/debate

Abstract

Rare disseminated tumor cells (DTCs) can persist after treatment in patients for years, and the immune system does not eliminate them. Goddard et al. propose that immune evasion by rare dormant DTCs is due to an improbability of contact imposed by large distances separating effector T cells and DTCs.

Original languageEnglish
Pages (from-to)13-15
Number of pages3
JournalCancer Cell
Volume42
Issue number1
DOIs
StatePublished - 8 Jan 2024
Externally publishedYes

Fingerprint

Dive into the research topics of 'Immune evasion by dormant disseminated cancer cells: A Fermi paradox?'. Together they form a unique fingerprint.

Cite this